What to do about low-grade squamous intraepithelial lesion (LSIL) in cervical TCT
Low-grade squamous intraepithelial lesion (LSIL) shown in cervical TCT testing indicates mild abnormal changes in cervical epithelial cells, usually caused by human papillomavirus (HPV) infection. Symptoms can be managed through regular follow-up examinations, HPV vaccination, cryotherapy, cervical conization, and drug therapy.
1. Regular Follow-up Examinations
For low-grade squamous intraepithelial lesions, it is recommended to follow medical advice for regular monitoring, such as undergoing a TCT test every six months or annually, to track whether the lesion progresses.
2. HPV Vaccination
Timely HPV vaccination is recommended, especially for young women, as it helps prevent cervical cancer and related cervical cellular abnormalities.
3. Cryotherapy
For certain cases of low-grade lesions, treatment with cryotherapy may be performed under a physician's supervision. This method freezes and destroys abnormal tissue to improve symptoms.
4. Cervical Conization
If the low-grade lesion persists or worsens, cervical conization is recommended under the care of a specialist to remove abnormal cervical tissue and alleviate symptoms.
5. Drug Therapy
When necessary, topical medications may be used under a doctor’s guidance. Commonly used drugs include fluorouracil injection, vinorelbine sulfate for injection, and vincristine sulfate for injection, which help eliminate abnormal cervical cells.
It is advisable to seek timely medical consultation and actively pursue treatment under professional guidance. Sexual intercourse should be avoided during treatment. Adequate rest, avoidance of excessive fatigue, and maintaining a balanced diet are beneficial for recovery.